TNFSF11 and breast cancer: Some authors raised the hypothesis of a synergistic effect of progesterone and E2 in BC tumorigenesis, in which the receptor activator of nuclear factor kappa-B ligand (RANKL) signalling pathway may be involved [15, 17].